Jim Wang

SVP, Head of Regulatory Affairs

Dr. Wang leads regulatory strategies and execution for the company’s product pipeline. He offers more than 17 years of global regulatory experience, including a decade in gene therapy that includes the submission and approval for LUXTURNA®, the first gene therapy targeting a genetic disease that received regulatory approval in both the U.S. and ...


Roles at Adverum Biotech

  • SVP, Head of Regulatory Affairs

    August, 2021 - present

By clicking "Continue" or continuing to use our site, you acknowledge that you accept our Privacy Policy and Terms of Use. We also use cookies to provide you with the best possible experience on our website.